Limited Edition Golden Llama is here! Check out how you can get one. 
Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Offering SPR-BLI Services - Proteins provided for free!
Thank you for choosing ACROBiosystems. Would you rate our product and service？ Thank you for choosing ACROBiosystems. Would you rate our product and service？
Here come GMP Grade Cytokines！Free Sample is available！ Here come GMP Grade Cytokines！Free Sample is available！
A-Z
> Overexpression cell line
Target & Transduction Research
Crossing-linking Drug Evaluation
Immune Checkpoint
Drug Evaluation
ADC Targeting & CAR-T
Cell Therapy[1]
Neuroscience[2]
Diabetes & Obesity & NASH
Drug Evaluation[3]
Autoimmunity Drug Evaluation[4]
Target & Transduction Research
Cross-linking Drug Evaluation
Immune Checkpoint Drug Evaluation
ADC Targeting & CAR-T Cell Therapy
Neuroscience
Diabetes & Obesity & NASH Drug Evaluation
Autoimmunity Drug Evaluation
| Molecule | Cat. No. | Product description |
|---|
| Molecule | Cat. No. | Product description |
|---|
| Molecule | Cat. No. | Product description |
|---|
| Molecule | Cat. No. | Product description |
|---|
| Molecule | Cat. No. | Product description |
|---|
| Molecule | Cat. No. | Product description |
|---|
| Molecule | Cat. No. | Product description |
|---|
Expression analysis of human CD64 on CHO/Human CD64 Stable Cell Line by FACS. Cell surface staining using PE-labeled anti-human CD64 antibody was performed on CHO/Human CD64 Stable Cell Line with different expression levels: CHO/Human CD64 Stable Cell Line (Low Expression) (Cat. No. SCCHO-ATP062L); CHO/Human CD64 Stable Cell Line (Medium Expression) (Cat. No. SCCHO-ATP062M); CHO/Human CD64 Stable Cell Line (High Expression) (Cat. No. SCCHO-ATP062H).
Bioactivity analysis of anti-human 4-1BB antibody through CHO/Human CD32b Stable Cell Line (Medium Expression) (Cat. No. SCCHO-ATP060M) crosslinking to test whether in a CD32b-dependent manner to strengthen the agonistic activity. The EC50 of anti-human 4-1BB antibody is approximately 0.18 μg/mL through CHO/Human CD32b Stable Cell Line (Medium Expression) crosslinking.
Blocking activity of anti-human PD-1 antibody (FOLD). This Raji/Human PD-L1 Stable Cell Line (Cat. No. SCRAJ-STT075) was incubated with serial dilutions of antibodies in the presence of reporter cells expressing human PD-1. The max induction fold was approximately 22.47.
[1]. Yu B, Jiang T, Liu D. BCMA-targeted immunotherapy for multiple myeloma. J Hematol Oncol. 2020;13(1):125. Published 2020 Sep 17. doi:10.1186/s13045-020-00962-7
[2]. Raimondo L, Oliveira ĹAF, Heij J, et al. Advances in resting state fMRI acquisitions for functional connectomics. Neuroimage. 2021;243:118503. doi:10.1016/j.neuroimage.2021.118503
[3]. Boland ML, Laker RC, Mather K, et al. Resolution of NASH and hepatic fibrosis by the GLP-1R/GcgR dual-agonist Cotadutide via modulating mitochondrial function and lipogenesis. Nat Metab. 2020;2(5):413-431. doi:10.1038/s42255-020-0209-6
[4]. Xue C, Yao Q, Gu X, et al. Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer. Signal Transduct Target Ther. 2023;8(1):204. Published 2023 May 19. doi:10.1038/s41392-023-01468-7
This web search service is supported by Google Inc.
アクロバイオシステムズの公式アカウント
